Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12451
PUT
Riskified
RSKD
$875M
| $45.4K | ﹤0.01% |
9,600
-18,400
| -66% | -$85.3K |
|
12452
CALL
Brookdale Senior Living
BKD
$3.02B
| $45.3K | ﹤0.01% |
9,000
-10,100
| -53% | -$57.8K |
|
|
SLI
12453
CALL
Standard Lithium
SLI
$587M
| $45.3K | ﹤0.01% |
31,000
+12,600
| +68% | +$23.2K |
|
12454
CALL
Fossil Group
FOSL
$329M
| $45.3K | ﹤0.01% |
27,100
+3,400
| +14% | +$4.97K |
|
12455
Electromed
ELMD
$341M
| $45.2K | ﹤0.01% |
1,530
-17,432
| -92% | -$455K |
|
|
ASA
12456
ASA Gold and Precious Metals
ASA
$1.1B
| $45.2K | ﹤0.01% |
+2,235
| New | +$46.6K |
|
|
WOW
12457
CALL
DELISTED
WideOpenWest
WOW
| $45.1K | ﹤0.01% |
9,100
-5,400
| -37% | -$27.6K |
|
12458
PUT
Enterprise Financial Services Corp
EFSC
$2.4B
| $45.1K | ﹤0.01% |
800
-200
| -20% | -$11.2K |
|
12459
Femasys
FEMY
$6.91M
| $45.1K | ﹤0.01% |
+2,048
| New | +$46.6K |
|
12460
PUT
Independent Bank
INDB
$4.07B
| $44.9K | ﹤0.01% |
700
| – | – |
|
12461
Eldorado Gold
EGO
$10.4B
| $44.9K | ﹤0.01% |
3,019
-184,650
| -98% | -$3.05M |
|
|
ADVM
12462
CALL
DELISTED
Adverum Biotechnologies
ADVM
| $44.8K | ﹤0.01% |
9,600
-13,600
| -59% | -$91.5K |
|
|
DCBO
12463
PUT
Docebo
DCBO
$584M
| $44.8K | ﹤0.01% |
1,000
-22,700
| -96% | -$1.07M |
|
|
ATYR
12464
aTyr Pharma
ATYR
$54.8M
| $44.7K | ﹤0.01% |
12,361
-954,246
| -99% | -$2.89M |
|
12465
CALL
Ultralife
ULBI
$125M
| $44.7K | ﹤0.01% |
6,000
-400
| -6% | -$3.29K |
|
|
NXLIW
12466
DELISTED
Nexalin Technology Inc Warrant
NXLIW
| $44.6K | ﹤0.01% |
121,275
-28,357
| -19% | -$10.3K |
|
12467
CALL
Ambev
ABEV
$43.2B
| $44.6K | ﹤0.01% |
24,100
-12,000
| -33% | -$26.5K |
|
12468
CALL
Abeona Therapeutics
ABEO
$343M
| $44.6K | ﹤0.01% |
8,000
-26,600
| -77% | -$164K |
|
12469
PUT
Hudbay
HBM
$11.9B
| $44.5K | ﹤0.01% |
5,500
-19,100
| -78% | -$171K |
|
12470
Research Solutions
RSSS
$77.6M
| $44.5K | ﹤0.01% |
10,735
-3,166
| -23% | -$10K |
|
12471
CALL
Invesco Golden Dragon China ETF
PGJ
$93.8M
| $44.5K | ﹤0.01% |
1,700
-13,000
| -88% | -$352K |
|
12472
CALL
Akebia Therapeutics
AKBA
$242M
| $44.5K | ﹤0.01% |
23,400
-104,100
| -82% | -$181K |
|
12473
PUT
GrowGeneration
GRWG
$104M
| $44.4K | ﹤0.01% |
26,300
-12,000
| -31% | -$23K |
|
12474
PUT
Paysign
PAYS
$744M
| $44.4K | ﹤0.01% |
14,700
+10,700
| +268% | +$37.5K |
|
12475
Crown Crafts
CRWS
$30.7M
| $44.3K | ﹤0.01% |
+9,892
| New | +$45.7K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.